Ritika Tyagi

Ritika Tyagi

I consult businesses as a Corporate Communicator where I help companies about the growth of the healthcare market.

Followers 3
Following 0
UK
The growth of the OTC tests market is mainly driven by the rising prevalence of target diseases and disorders, such as diabetes and infectious diseases, both prominent ailments across the globe that require rapid and effective testing.The OTC tests market is projected to reach USD 22.2 billion by 2024 from USD 11.9 billion in 2018, at CAGR of 11.0% during the forecast period.Infectious disease tests are expected to be the fastest-growing segment in the OTC Test market during the forecast period.The infectious disease tests segment is projected to grow at the highest CAGR between 2018 and 2024.Growth in this market can be attributed to factors such as the increasing number of HIV-infected individuals across the globe, coupled with increasing availability and awareness about HIV OTC testing in emerging markets such as India, Brazil, and China.Lateral flow assays segment is growing at the highest rate.The lateral flow assays segment is projected to grow at the highest rate in the market, by technology.In the past few years, the lateral flow assay POC testing market has grown significantly due to the increasing adoption of LFA testing products in home care.Companies are increasingly focusing on the development of innovative LFA-based OTC devices for the confirmation of pregnancy (using hCG levels) and ovulation, screening for infectious diseases and drugs of abuse are the factors expected to drive the growth of these markets during the forecast period.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78819178The market in the Asia Pacific is growing at the highest CAGR during the forecast period.The Asia Pacific is estimated to grow at the highest CAGR during the forecast period.The high growth in this regional segment is majorly attributed to the increasing patient population base and the growing prevalence of infectious diseases.Key market playersThe key players operating in the global Over The Counter/OTC test industry are OraSure Technologies (US), Roche Diagnostics (Switzerland), and i-Health Lab (US).A majority of the leading players in the market focus on both organic and inorganic growth strategies such as collaborations, partnerships, acquisitions, and agreements to maintain and enhance their market shares in the OTC tests market.Inquiry about Over The Counter/OTC Test Market before buying @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=78819178 
1
IT
The growth of this market is primarily driven by majorly driven by the growth in the target patient population (suffering from cardiovascular diseases, neurovascular disorders, and cancer), rising adoption of minimally invasive surgical procedures, and the increasing number of microcatheter-assisted clinical research studies.The global microcatheters market is projected to reach USD 924 Million by 2024 from USD 688 Million in 2018, at a CAGR of 5.0% from 2018 to 2024.The steerable microcatheters segment is expected to grow at fastest CAGR during forecast period owing to the growing number of image-guided and minimally invasive medical procedures across major countries, shift from manually operated devices towards robotically operated surgical platforms, rising prevalence of vascular diseases, and the procedural advantages associated with steerable microcatheters.The liver cancer segment was the largest contributor to the microcatheters market, by cancer type in 2018Based on cancer type, the microcatheters market is segmented into liver cancer, kidney cancer, lung cancer, bone cancer, and other cancers (includes pediatric cancer, prostate cancer, and breast cancer).The large share of this segment is attributed to factors such as rising cases of liver cancer across the globe and growing initiatives/research activities for developing advanced liver cancer therapies using microcatheters.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=184715728Asia Pacific is expected to grow at the highest CAGR in the microcatheters market during the forecast periodNorth America is expected to account for largest share in the global microcatheters market in 2018.Emerging economies in the region such as India, China, and South Korea along with developed markets such as Japan and Australia are offering high-growth opportunities for market players in the field of microcatheters.This can be attributed to factors such as presence of a large patient pool, increasing prevalence & incidence of target diseases, growing healthcare infrastructure in Asian countries, and favorable government initiatives.Leading CompaniesThe major players operating in the global microcatheters industry include Boston Scientific Corporation (US), Medtronic Plc (Ireland), Terumo Corporation (Japan), ASAHI INTECC CO., LTD. (Japan), MERIT MEDICAL SYSTEMS, INC. (US), Teleflex Incorporated (US), Johnson and Johnson (US), Stryker Corporation (US), Cook Group Incorporated (US), Cardinal Health, Inc. (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), AngioDynamics, Inc. (US), Penumbra (US), and BTG PLC (UK), among others.An analysis of the market developments between 2015 and 2019 revealed that several growth strategies such as product launches and enhancements, partnerships, collaborations, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the microcatheters market.
1
AT
The growth of this market is majorly driven by the increasing research in the life sciences industry and the growing need to identify antigens associated with autoimmune diseases (through antigen-antibody interaction to understand disease mechanisms and develop relevant drugs targeting these diseases).The immunoprecipitation market is expected to grow from USD 560 million in 2018 to USD 750 million by 2024, at a CAGR of 5.0% during the forecast period.By product type, kits are expected to be the fastest-growing segment in the immunoprecipitation market during the forecast period.The kits segment is projected to grow at the highest CAGR between 2018 and 2024.Growth in this market can be attributed to factors such as the requirement for repeat purchase of kits, coupled with the increasing number of IP assays to isolate and purify antigens.By type, the Individual IP segment is growing at the highest rate.The individual IP segment is projected to grow at the highest rate in the market, by type.The increasing use of IP in studying protein-protein interactions, to detect the presence of an antigen, and to determine the relative quantity of an antigen are driving the use of individual IP in various research studies during the forecast period.Request for Sample Pages @https://www.marketsandmarkets.com/requestsampleNew.asp?id=78538655The market in the Asia Pacific is growing at the highest CAGR during the forecast period.The Asia Pacific is estimated to grow at the highest CAGR during the forecast period.Increasing investments by governments and industries, growing biotechnology research in these regions, and rising awareness about personalized therapeutics are expected to drive the growth of these markets during the forecast period.Key market playersMajor immunoprecipitation vendors include Thermo Fisher Scientific (US), Abcam (UK), Bio-Rad Laboratories (US), Merck KGaA (Germany), GenScript.(US), and BioLegend (US), Cell Signaling Technology (US), Rockland Immunochemicals (US), Takara Bio (Japan), and Geno Technology (US).Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78538655
1
UK
Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS).However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries.The ligation devices market is projected to reach USD 1,189 million by 2024 from USD 876 million in 2019, at a CAGR of 6.3%.Accessories are expected to fuel the growth of the ligation devices market over the forecast period.By product, the ligation devices market is segmented into handheld instruments and accessories.The accessories segment accounted for a share of 68.2% in 2018 and is anticipated to grow at a CAGR of 6.9% during the forecast period.This growth can be attributed to the increasing number of surgical procedures, especially in emerging markets.Increasing use of ligation devices in gastrointestinal & abdominal surgeries to drive market growth during the forecast periodBased on applications, the ligation devices market is segmented into gastrointestinal & abdominal surgeries, gynecological surgeries, cardiovascular surgeries, urological surgeries, and other applications such as wound, ENT, and cosmetic applications.The cardiovascular surgeries segment is anticipated to drive growth in the market at a CAGR of 6.9% over the forecast period.This growth can be attributed to the increase in the incidence of cardiovascular diseases.
1
UK
The increase in the prevalence of lung cancer & chronic respiratory disorders globally, combined with the increasing preference for minimally invasive procedures are some of the factors contributing to the growth of this market.However, the associated complication of using these stents and an increase in the availability of alternative treatments might hamper the growth of the airway/lung stents market.The lung stent market is projected to reach USD 120 million by 2024 from USD 87 million in 2019, at a CAGR of 6.7%.The market is segmented based on the type, material, product, end user, and region.Based on the type, the tracheobronchial segment accounted for the largest share of the airway stent/lung stent market in 2018.The large share of this segment can be attributed to the higher adoption trends seen in the tracheal and bronchial stents for use in the treatments of respiratory disorders.Based on material, the airway stent/lung stent market is divided into metal, silicone, and hybrid stents.In 2018, metal stents accounted for the largest share in the airway stent/lung stent market.The advantages associated with metal stents, such as ease of insertion, thinner walls as compared to silicone lung stents, a lower risk of dislodgment or migration, and ability to adapt to the twisted airway are driving the growth of this segment.Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32315890By product, the airway stent/lung stent market is segmented into expandable and non-expandable stents.
1
UK
The global Parkinsons disease treatment market is expected to reach USD 5.69 billion by 2022 from USD 4.24 billion in 2017, at a CAGR of 6.1%.In the severe stages, medications do not show pharmacological action in relieving disease symptoms.Neurologists perform thalamotomy, pallidotomy, or implant deep brain stimulation (DBS) devices in order to ease symptoms.Moreover, the focus on gene therapy research has increased.According to the Parkinson’s Disease Clinic and Research Center, University of California, US, gene therapy for Parkinson’s disease has shown promising results in phase I studies.Surgical treatments, restriction on the use of medications in severe stages of the disease, and the increased focus on gene therapy research are expected to restrain the demand for therapeutic drugs used in Parkinson’s disease.Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=47265247The Parkinson’s disease treatment market is segmented on the basis of drug class, distribution channel, patient care setting, and region.On the basis of drug class, the market is segmented into carbidopa/levodopa, dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs.
1
UK
The report “Neuroprosthetics Market by Type (Output (Cognitive, Motor Prosthetics), Input (Cochlear, Retinal Implant)), Techniques (Deep Brain, Vagus Nerve, Spinal Cord stimulation), Application (Epilepsy, Paralysis, Alzheimer’s Disease) – Global Forecast to 2022″, The neuroprosthetics market is expected to reach USD 10.48 Billion by 2022 from USD 5.84 Billion in 2017, at a CAGR of 12.4% from 2017 to 2022.Increasing number of neurological disorders, increasing incidence of hearing loss, increasing prevalence of diabetes, and increasing cases of amputation due to the rising number of accidents & injuries are major factors that are driving the growth of this market.Browse 84 market data Tables and 31 Figures spread through 118 Pages and in-depth TOC on “Neuroprosthetics Market”Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=234147399By input neural prosthetics, the cochlear implants segment is expected to dominate the market in 2017On the basis of input neural prosthetics is subsegmented into cochlear implants and bionic eye/retinal implants.The cochlear implants segment accounted for the largest share of this market segment.This growth can be attributed to the increasing number of people suffering from hearing loss which drives this segment.By technique, the spinal cord stimulation segment is expected to dominate the market in 2017In the technique, the neuroprosthetics market is segmented into spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and transcranial magnetic stimulation.The spinal cord stimulation segment holds the largest share in the market.The growth is primarily attributed to the increasing number of people suffering from back surgery syndrome, ischemia, and chronic pain across the globe.Request for Sample Pages @https://www.marketsandmarkets.com/requestsampleNew.asp?id=234147399Asia Pacific offers lucrative growth opportunitiesBy region, the global neuroprosthetics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW).
3
UK
The growing number of dentists is one of the major drivers for the growth of the dental CBCT market in this region.This increase, along with the subsequent establishment of new clinics and rising government spending on healthcare, has contributed to a growing demand for dental equipment like CBCT systems.The EMEA 3D CBCT systems market is projected to reach USD 300.4 Million by 2023 from USD 194.3 Million in 2018, at a CAGR of 9.0%.This report analyzes the EMEA 3D CBCT systems market by application, end user, and region.Based on application, the market is broadly segmented into dental and non-dental applications.The dental application segment accounted for the largest share of the EMEA 3D CBCT systems market.The large share of this segment can be attributed to the rapidly growing geriatric population, increase in the prevalence of dental diseases/conditions, low radiation exposure from CBCT compared to conventional analog X-rays, growing demand for cosmetic dentistry, and growing medical tourism for dental services.Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=148086734By type, the dental application segment is further subsegmented into implantology, oral and maxillofacial surgery, orthodontics, endodontics, and other dental applications.The ability of CBCT to provide greater accuracy in measurements at lower radiation doses has made it the preferred option in implant dentistry.
1
AT
Factors contributing to the growth of this market include the rising incidence and prevalence of chronic and infectious diseases, growing funding for cancer research, growing cell-based research, and development of apoptosis-modulating drugs.The global apoptosis assays market is projected to reach USD 5.9 billion by 2023 from USD 3.6 billion in 2018, at a CAGR of 10.5%.Based on detection technology, the cell imaging and microscopy is expected to grow at the fastest growth rate during the forecast period.The cell imaging and microscopy segment is expected to witness the highest CAGR due to its increasing adoption of cell imaging and microscopy in diagnostic laboratories, drug discovery applications, and basic research.On the basis of product, the assay kits segment is expected to account for the largest share of the market in 2018.The large share can be attributed to the repeated consumption of assays in various apoptosis procedures.On the other hand, among all the detection technology, the flow cytometry is most widely used for apoptosis process.Geographical Region CoveredThe apoptosis assays market in APAC is expected to grow at the highest CAGR during the forecast period.The highest CAGR is due to the increasing prevalence of chronic and infectious diseases in this region, large patient population, increasing healthcare spending, and growing interest of key players in APAC countries.Also, owing to the high growth opportunities in the APAC region, many manufacturers are expanding their global manufacturing bases to this region.
1
AT
Chatbots are used for various applications in healthcare industry.Patient data contain personal, private, or confidential information and requires strict safeguards to prevent its misuse.This is a very difficult task as most AI-based platforms are consolidated and require extensive computing power owing to which patient data, or part of it, can be required to reside in a vendor’s data set.Growing usage of healthcare chatbots by clinicians and hospitals to increase their patient engagement rate, are driving the growth of the healtchcare chatbots market.PatientsPatients are the largest end users of healthcare chatbots.Healthcare chatbots interact with potential patients visiting a site, provide a possible diagnosis, help find specialists, schedule appointments, and improve access to the right treatments.Healthcare providers need to identify diseases and analyze a large amount of healthcare information to make critical decisions.In an effort to improve the quality of care and reduce costs, healthcare providers are increasingly turning to IT-enabled strategies and software for the appropriate identification of diseases and better treatment alternatives.
1
AT
increasing R spending in the pharmaceutical and biopharmaceutical industries and increasing purity requirements among end users of track etched membranes.However, the high cost of production and the limited supply of track etched Membranes are major factors that are expected to restrain the growth of this market during the forecast period.How much is the Track etched Membrane Market worth ?The track etched membrane market is expected to reach USD 813.1 million by 2023 from USD 476.0 million in 2018, at a CAGR of 11.3% from 2018 to 2023.Scope of the Report:The research report categorizes the track etched membrane market into the following segments and subsegments:Track Etched Membrane Market, By ProductMembrane FiltersCapsule & Cartridge FiltersOther Track Etched Membrane ProductsTrack Etched Membrane Market, By MaterialPolycarbonatePolyethylene TerephthalatePolyimideTrack Etched Membrane Market, By ApplicationCell BiologyMicrobiologyAnalytical TestingOther ApplicationsTrack Etched Membrane Market, By End UserPharmaceutical and Biopharmaceutical CompaniesAcademic and Research InstitutesFood and Beverage CompaniesHospital and Diagnostic CentersTrack Etched Membrane Market, By RegionNorth AmericaUSCanadaEuropeGermanyUKFranceItalySpainRest of Europe (RoE)Asia PacificRest of the WorldThe commercial production of track etched membranes is almost always a secondary operation, and the production time is dependent on the time consumed by the primary operation of the facility.Facilities for beaming or irradiation are limited and in most cases are operated by government agencies, universities, or research laboratories.Although track etched membranes can be produced with a precisely determined pore size, shape, and distribution, their conventional production is very expensive for large-scale separation processes.Heavy ion irradiation of thin polymer films at a nuclear reactor or large accelerator facilities, which involves large capital costs, is generally the key initial manufacturing stage for track etched membranes.This cost is prohibitive or unaffordable for most consumers of Industrial Filtration systems.Moreover, considering the high costs, end users such as diagnostic laboratories and research institutes prefer the use of low-cost alternatives such as depth filters.
1
AT
The report “Biological Safety Cabinet Market by Type (Class I, Class II (Type A, Type B), Class III), End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories, Academic & Research Institution) – Global Forecast to 2022”, the biological safety cabinets market is projected to reach USD 205.9 Million by 2022 from USD 144.3 Million in 2017, at a CAGR of 7.4%.Growth in the biological safety cabinets market is primarily driven by factors such as favorable regulations driving the use of biological safety cabinets in the healthcare industry, increased risk of pandemics and communicable diseases, increasing number of R activities in biotechnological and pharmaceutical companies, and rapid growth in the number of biologics.Browse 61 market data Tables and 28 Figures spread through 114 Pages and in-depth TOC on “Biological Safety Cabinet Market by Type (Class I, Class II (Type A, Type B), Class III), End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories, Academic & Research Institution) – Global Forecast to 2022”https://www.marketsandmarkets.com/Market-Reports/biological-safety-cabinet-market-60228904.htmlEarly buyers will receive 10% customization on reports.The Class II biological safety cabinets segment accounted for the largest share of the market in 2017On the basis of type, the biological safety cabinets market has been segmented into Class I, Class II, and Class III biological safety cabinets.The Class II biological safety cabinets segment accounted for the largest share of the biological safety cabinet’s market in 2017.The large share and high growth of this segment can primarily be attributed to the high level of protection offered by these cabinets.Pharmaceutical & biopharmaceutical companies held the largest share of the market in 2017On the basis of end user, the biological safety cabinets market has been segmented into pharmaceutical & biopharmaceutical companies, diagnostic and testing laboratories, and academic & research institutions.In 2017, the pharmaceutical & biopharmaceutical companies segment accounted for the largest share of the biological safety cabinets market.This segment is also projected to grow at the highest CAGR during the forecast period.
1
IN
The ongoing COVID-19 pandemic—and the worldwide reaction to it—has compelled companies to radically rethink their strategies and the way they operate.We salute the industry experts helping companies survive and sustain in this pandemic.At MarketsandMarkets™, analysts are undertaking continuous efforts to provide analysis of the COVID-19 impact on the Injection Pen Market.We are working diligently to help companies take rapid decisions by studying: The impact of COVID-19 on the Injection Pen Market, including growth/decline in product type/use cases due to the cascaded impact of COVID-19 on the extended ecosystem of the market The rapid shifts in the strategies of the Top 50 companies in the Injection Pen Market The shifting short-term priorities of the top 50 companies’ clients and their client’s clients You can request an in-depth analysis detailing the impact of COVID-19 on the Injection Pen Market: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=42342539According to the new market research report “Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region — Global Forecast to 2022”, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).Don’t miss out on business opportunities in Injection Pen Market.The growth of this market is primarily driven by factors such as the growing prevalence of chronic diseases, increasing number of regulatory approvals, and favorable reimbursement in developed countries, and government support.The market is segmented on the basis of type, therapy, end user, and region.Based on type, the market is segmented into disposable and reusable injection pens.The disposable injection pens segment is expected to grow at the highest CAGR during the forecast period.The high growth of this segment can be attributed to the benefits disposable pens offer, such as portability, ease of use, and low possibility of infection.Browse and in-depth TOC on “ Injection Pen Market “109 — Tables36 — Figures185 — PagesDownload an Illustrative overview of the report — https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=42342539The home care segment dominated the market on the basis of end users in 2017The injection pen market is segmented on the basis of end users into home care and hospital & clinics.
1
UK
Blood collection is the process of acquiring blood samples from the donor for performing laboratory diagnostic tests and treating patients.This is an integral part of the blood management procedure in hospitals and blood banks centers.The global blood collection market is expected to reach USD 10.59 Billion by 2022 from USD 8.10 Billion in 2017, at a CAGR of 5.5% during forecast period.The increasing prevalence of various diseases, rising number of surgeries, and growing number of accidental and trauma cases are fueling the demand for blood collection products.Blood collection devices segment is expected to grow at the highest growth rate during the forecast period.The blood collection devices segment is projected to register the highest during the forecast period.The growth of this market segment is driven by the rising prevalence of blood disorders, increasing demand for plasma from biopharmaceutical companies for plasma fractionation, and rising demand for apheresis & whole blood collection devices from blood banks in the emerging countries.Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39733117Automated blood collection segment to record the highest CAGR during the forecast period.Automated blood collection segment is projected to register a higher CAGR during the forecast period.The growth of the automated blood collection segment can be attributed to the increasing demand for safer procedures to withdraw and separate blood components for transfusion; availability of advanced blood collecting products such as blood bags with inbuilt filters, blood collection monitors, and tube sealers; and the rising demand for plasma by biopharmaceutical companies.Hospitals and pathology laboratories segment to record the highest CAGR during the forecast period.Clinics, big hospitals, multi-specialty hospitals, pathology laboratories, and in-house blood banks is projected to register a higher CAGR during the forecast period.The growth of the this segment can be attributed to the increasing prevalence of diseases for which blood diagnosis is essential.Moreover, the number of organ transplant surgeries has increased over the last decade.
1
UK
The global bioresorbable stents market is expected to reach USD 417.2 Million by 2022 from USD 223.6 Million in 2016, at a CAGR of 11.5% during the forecast period 2017–2022.Market growth of bioresorbable stents is attributed to the growing aging population susceptible to coronary and peripheral artery diseases, rising PCI procedures, increasing focus of companies on clinical trials of bioresorbable stents, increasing adoption of these stents by physicians and patients, and patients’ preference for minimally invasive therapies.However, factors such as the increasing product withdrawals due to severe complications of these stents may hamper market growth.Browse 73 Market Data Tables and 33 Figures spread through 138 Slides and in-depth TOC on “Bioabsorbable Stent/Bioresorbable Scaffold Market”http://www.marketsandmarkets.com/Market-Reports/bioabsorbable-stent-market-40983380.htmlEarly buyers will receive 10% customization on this reportThe growth of the market is attributed to growing aging population susceptible to coronary and peripheral artery diseases, rising PCI procedures, increasing focus of companies on clinical trials of bioresorbable Stent, increasing adoption of these Stent by physicians and patients, and preference for minimally invasive therapies.Bioresorbable polymer-based Stent projected to grow at the highest CAGRBased on material, the market is segmented into bioresorbable polymer-based Stent and bioresorbable metallic Stent.The bioresorbable polymer-based Stent segment is expected to grow at the highest CAGR during the forecast period.The growth of this market is attributed to companies’ increasing focus on developing polymeric Stent and approvals being granted for polymer-based Stent across various regionsDownload PDF Brochure:http://www.marketsandmarkets.com/pdfdownload.asp?id=40983380Based on applications, the coronary artery diseases are expected to dominate the market in 2017Based on application, the market is segmented into coronary artery diseases and peripheral artery diseases.In 2017, coronary artery diseases accounted for the largest share of the market.The dominance of this segment is attributed to factors such as increasing aging population prone to coronary artery diseases and the adoption of unhealthy lifestyle habits leading to increased risk of these diseases.Europe to dominate the market during the forecast periodIn 2017, Europe is expected to account for the largest share of the market.
1
UK
Advantages of companion diagnostics, the growing need for targeted therapy, the rising importance of personalized medicine, the increasing global incidence of cancer, and the ever-increasing application areas of companion diagnostics are driving the growth of the global companion diagnostics industry.The increasing demand for next-generation sequencing, the growing significance of companion diagnostics in drug development, and the rising number of clinical trials are the major factors driving the growth of this market.[333 Pages Report] The companion diagnostics market is expected to reach USD 6.8 billion by 2025 from USD 3.7 billion in 2020, at a CAGR of 12.9% during the forecast period of 2020 to 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155571681COVID-19 Impact on Companion Diagnostics MarketThe companion diagnostics market includes major Tier I and II companies like Roche Diagnostics, Agilent Technologies, Qiagen, Thermo Fisher, and Abbott Laboratories.These suppliers have their manufacturing facilities spread across various countries across Asia Pacific, Europe, North America, South America, and RoW.The lockdown and restrictions related to social distancing implemented in these COVID-19 countries had negatively affected the supply chain of these products.Polymerase chain reaction (PCR) segment to account for the largest share of the companion diagnostics marketThe polymerase chain reaction segment is expected to dominate the companion diagnostics market in 2019.The large share of this segment can be attributed to the ease of use and widespread availability of PCR kits & reagents in companion diagnostic testing, growing applications of PCR in the high-throughput detection of mutants with a limited or low allele frequency of genes, and high turnaround time of PCR as compared to other technologies.Pharmaceutical & biopharmaceutical companies are estimated to be the largest end-users of companion diagnosticsPharmaceutical & biopharmaceutical companies are expected to account for the largest share of the companion diagnostics market in 2019.
1
AT
Growth in the fetal and Neonatal care equipment market is mainly driven by the rise in number of preterm and low-weights birth infants, growing number of NICU admissions, and increased awareness of neonatal and fetal care across developing nations.Growth in the in fetal dopplers segment can be attributed to factors such as the growing demand for digital Dopplers over conventional Dopplers and increasing launches of home-use products.The growing popularity of and demand for fetal Doppler devices is increasing due to the procedural advantages these devices offer, such as ease of use, mobility (handheld and battery-operated products), novel features, and display functionalities.The rising adoption of Doppler imaging (especially in first trimester of pregnancy and for the diagnosis of restricted fetal growth), growing preference for the assessment of the fetal-placental circulatory system, expansion of application horizon for fetal Doppler imaging (such as in aneuploidy screening and transfusion syndrome), and the growing availability of home-use & new smartphone-based fetal monitoring systems.Download PDF Brochure – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=412An incubator is a closed environment where temperature, moisture, and oxygen levels can be regulated.However, babies in incubators are less accessible as compared to warmers.The major factor driving the growth of this segment is the rising incidence of neonatal hypothermia.The large share of the Incubators segment can be attributed to Development of novel neonatal incubators, rising incidence of neonatal hypothermia, and increasing number of NICU admissions.
1
AT
In addition to the availability of advanced healthcare facilities, the cost of an IVF cycle in India is around 70% lower than that of some developed countries.Thus, the low cost of the procedure and quality healthcare facilities in Asian countries will create growth opportunities for the IVF market.In addition to low treatment costs, coupled with high-quality treatments, the presence of liberal laws regarding the IVF treatment is also driving fertility tourism in emerging Asian countries such as India and Thailand.For instance, Thailand is attracting couples for IVF treatment because of its liberal IVF regulations such as gender selection of the embryo before implantation, whereas IVF is banned for couples with a certain number of children in China and the IVF technology is entirely banned under all circumstances in Costa Rica.Also, clinics in India are permitted to transfer six embryos simultaneously, whereas clinics in the UK are allowed to implant two embryos.In the European region, Spain is the preferred destination for IVF as the country has liberal laws regarding the treatment, with shorter waiting lists and higher success rates compared to other European countries.Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89198891Challenge: Reducing efficacy of infertility treatment with advancing ageThe changing social scenario has resulted in an increasing number of older women seeking help from infertility clinics.As a woman ages, it takes her longer to conceive, and the chances of not being able to conceive also increase.Also, the risk of miscarriage and complications in pregnancy and childbirth increase with age.According to the American Society for Reproductive Medicine, a 30-year-old healthy and fertile woman has about 20% chance of getting pregnant without assistance every month, whereas, for a woman aged 40 years or above, the chance decreases to 5%.
1
AT
According to latest research report”3D Printing Medical Devices Market by Technology (3DP, EBM, LBM, Photopolymerization and DD), Component (3D Printers, 3D Bioprinters, Material (Plastic, Metal, Ceramic), Software & Services), Product Type (Prosthetics, Implant) – Global Forecast to 2022″, 3D Printing Medical Devices Market is expected to reach $1.88 billion by 2022, at CAGR of 17.5% from 2017 to 2022.Technological advancements in 3D printing and increasing public-private funding for 3D printing activities are to drive the overall 3D printing medical devices market during the forecast periodBased on technology, the market is segmented into suture 3D printing medical devices, electron beam melting (EBM), laser beam melting (LBM), photopolymerization, droplet deposition or extrusion-based technologies, PolyJet technology, and three-dimensional printing (3DP) or adhesion bonding or binder jetting.The photopolymerization segment is expected to hold the largest share of the 3D printing medical devices market in 2017.This is attributed to the widespread application of this technology across the medical industry, for manufacturing surgical guides (orthopedic, dental, and CMF guides), prosthetics and implants, porous scaffolds, and dental restorations.Browse 78 Market Data Tables and 31 Figures spread through 198 Pages and in-depth TOC on “Global 3D Printing Medical Devices Market”.Download PDF Brochures –https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90799911The surgical guides segment is expected to hold the largest market share in 2017On the basis of type, the overall market is segmented into surgical guides, surgical instruments, prosthetics & implants, and tissue engineering products.The surgical guides segment is expected to account for the largest share of the market in 2017.3D printing surgical guides as a part of surgical planning can significantly improve the precision of implant placement and provide accurate implant restorations.Due to this, the demand for precise and affordable guides is increasing; this is the key factor driving the growth of this market segment.Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=90799911North America is expected to dominate the market in 2017As of 2017, North America held the largest share of the overall market, followed by Europe.Its large share is attributed to the rising demand for organ transplants across this region.The presence of a highly developed healthcare infrastructure and significant government & private investments to develop advanced 3D printing technologies & applications are the key factors responsible for the large share of this regional segment.Additionally, conferences and trade are also supporting the growth of the market in North America.Leading CompaniesStratasys Ltd. (Israel and US), 3D Systems Corporation (US), Materialise NV (Belgium), EnvisionTEC GmbH (Germany), EOS GmbH Electro Optical Systems (Germany), Renishaw plc (UK), Concept Laser GmbH (Germany), 3T RDP, Ltd. (UK), Prodways (France), Arcam AB (Sweden), Anatomics Pty Ltd (Australia), Biomedical Modeling Inc. (US), Carbon, Inc. (US), and SLM Solutions Group AG (Germany), Organovo Holdings, Inc. (US), among othersStratasys Ltd. (Israel & US) held the leading position in the global 3D printing medical devices market in 2016.
2
UK
New market research report on “Inspection Machine Market by Product (Vision Inspection, Checkweigher metal detector , Software) Type (Automatic, Manual), Packaging (Ampoules, Vials, Blisters, Bottles), user (Pharmaceutical, Medical Devices, Food) — Global Forecast to 2024”, published by MarketsandMarkets™, the Inspection Machines Market is projected to succeed in USD 774 million by 2024 from USD 592 million in 2019, growing at a CAGR of 5.5% between 2019 and 2024.Don’t miss out on business opportunities in Inspection Machines Market.The increasing expenditure in medical manufacturing to make sure compliance with Good Manufacturing Practices and therefore the rising penetration of automation are a number of the main factors that are expected to drive the growth of this market during the forecast period.The introduction and implementation of numerous regulatory mandates in the healthcare sector and the adoption of new technologies in line with the increasing number of inspection checkpoints throughout the whole production cycle within the pharmaceutical and biotechnology sectors also are expected to support market growth within the coming years.Vision inspection systems segment to account for the most important share of the Inspection Machines Market, by productThe vision inspection systems segment is predicted to account for the most important share of the Market, by product, in 2019.The high demand for inspecting components for size, shape, color, or reading in pharmaceutical, nutraceutical, chemical, medical device, and food & beverage industries is one among the main factors driving the growth of this segment.Browse in-depth TOC on “Inspection Machines Market”150 — Tables32 — Figures215 — PagesDownload PDF Brochures — https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81453085Food processing & packaging companies to make the fastest-growing end-user segment within the Inspection Machines MarketAmong all end-user segments, the demand for inspection machines is estimated to grow at the very best rate among food processing & packaging companies.This can majorly be attributed to the growing demand for processed foods, increasing consumer awareness regarding food safety, and therefore the growing demand for minimizing human errors in food processing and packaging.North America is estimated to be the most important regional marketplace for inspection machinesNorth America is estimated to account for the largest share of the Market in 2019, closely followed by Europe.Factors like the strong presence of various pharmaceutical & medical device manufacturers and therefore the presence of stringent regulatory frameworks for these manufacturers (including a rise within the number of inspection checkpoints within the production line) and highly monitored inspection standards are driving the expansion of the Inspection Machines Market in North America.Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=81453085
3
IN
Increasing adoption of behavior health software, availability of government funding, government initiatives to encourage EHR adoption in behavioral health organizations, favorable behavioral health reforms in the US, and high demand for mental health services amidst provider shortage are the major factors driving the growth of this market.What the Behavioral Health Software Market Looks Like?Predicted to grow at a CAGR of 14.8 % during the forecast period, the global behavioral health software market is estimated to reach USD 2.31 billion by 2022.In 2017, North America is expected to dominate the mental health software market, followed by Europe.What are the Behavioral Health Software Market Segments?This report segments the behavioral health software market into component, delivery model, functionality, end user, and region.Based on component, the market is segmented into software and support services.The support services segment is expected to account for the largest share of the market in 2017.The recurring requirement of support services (such as for software upgrades and maintenance) is the major factor supporting its growth.Based on delivery model, the mental health software market is segmented into ownership models and subscription models.High growth in the clinical functionality segment is attributed to the increasing government initiatives to boost adoption of this software by clinicians to provide quality care to their patients at lower costs.Based on the end user, the behavioral health software market is segmented into providers, payers, and patients.
2
IN
Patient monitoring devices for continuous monitoring, detection, and treatment of heart, brain, lungs, and blood activities and measurement of temperature and weight of the body. Patient Monitoring Devices Market by Product (EEG, EMG, MEG, TCD, Peak Flow Meter, Pulse Oximeter, Fetal Monitoring, Temperature Monitoring Devices, MCOT, ECG, Hemodynamic Monitoring System), End User (Home, Hospital). Availability of wireless patient monitoring devices The integration of monitoring technologies in smartphones and wireless devices is a key trend in patient care, resulting in the introduction of remote patient monitoring systems, mobile cardiac telemetry devices, mobile personal digital assistant (PDA) systems, ambulatory wireless EEG recorders, and ambulatory event monitors. Remote patient monitoring devices help enhance patient care delivery and improve patient outcomes for conditions that need continuous monitoring in hospital and non-hospital settings. Download PDF Brochure – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=678 Emerging markets The healthcare industry in emerging countries (such as India, China, Brazil, and Mexico) will offer significant growth opportunities for patient monitoring device manufacturers owing to the increasing patient population across these countries, coupled with the rising adoption of patient monitoring devices in these countries. Moreover, emerging countries have registered a sustained increase in the volume of surgical procedures during the past decade, driven by the growing target patient population, the presence of a supportive regulatory environment, and rising medical tourism.
1
IN
Peripheral Vascular Devices Market Report OverviewThe peripheral vascular devices market is projected to reach USD 14.4 billion by 2024 from USD 10.3 billion in 2019, at a CAGR of 6.8% during the forecast period.The rapid growth in the geriatric population and the associated increase in the prevalence of peripheral vascular diseases, approval of new and advanced products, and the growing preference for minimally invasive surgeries are driving the growth of the peripheral vascular devices.Atherectomy devices accounted for the larger share of the plaque modification devices market in 2018On the basis of type, the plaque modification devices market is segmented into atherectomy devices and thrombectomy devices.In 2018, the atherectomy devices segment accounted for the larger market share mainly due to the increasing incidence of atherosclerosis as a result of the rising global prevalence of obesity.Embolic protection devices accounted for the largest share of the peripheral vascular devices market in 2018On the basis of type, the hemodynamic flow alteration devices market is segmented into embolic protection devices and chronic total occlusion devices.In 2018, the embolic protection devices segment accounted for the larger share of the hemodynamic flow alteration devices market.This can be attributed to the advantages of EPDs over CTO devices, such as the ability to capture embolic debris without interrupting continuous blood flow.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=790North America dominates the peripheral vascular devices marketNorth America, which includes the US and Canada, accounted for the largest share of the peripheral vascular devices market in 2018.The large share of this market segment can be attributed to the rising incidence of peripheral vascular diseases (PVDs), growing geriatric population, and the strong presence of industry players in the region.Growth in this market is majorly driven by the rapid growth in the geriatric population and the associated increase in the prevalence of peripheral vascular diseases, approval of new and advanced products, and the rising prevalence of diabetes.
1
IN
The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%.The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market.On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth.By type, metallic biomaterials segment is expected to hold the largest share of the dental biomaterials market during the forecast period.Based on type, the market is segmented into metallic, metal-ceramic, ceramic, polymeric, and natural dental biomaterials the metallic biomaterials segment accounted for the largest share in 2018.The large share of this segment can be attributed to the increasing penetration of dental implants and the wide applications of metallic biomaterials in dentistry.Request for Sample Pages – https://www.marketsandmarkets.com/requestsampleNew.asp?id=198160556Implantology applications to dominate the dental biomaterials market through the forecast periodBy application, the market is categorized into implantology, prosthodontics, orthodontics, and other applications.In 2018, the implantology application segment accounted for the largest share of the market.The large share of this segment can be attributed to the increasing penetration of dental implants globally, high price and volume requirements of titanium used in manufacturing dental implants, rising incidence of dental diseases, increasing demand for cosmetic dentistry, growing dental tourism in emerging markets, and increasing disposable incomes in developing countries.Dental implant and prosthetic manufacturers to hold the largest share of the dental biomaterial market during the forecast periodBased on the end user, the market is segmented into dental implant and prosthetic manufacturers, dental laboratories, dental hospitals and clinics, and dental academies and research institutes.
2
IN
According to a new market research report “Medical Holography Market by Product (Holographic Display, Microscope, Print, Software), Application (Medical Imaging, Medical Education, Biomedical Research), End User (Medical Schools, Pharmaceutical Companies, Hospitals) – Global Forecast to 2021” published by MarketsandMarkets, The Global Medical Holography Market Is Projected to Reach USD 953.9 Million by 2021, at a CAGR of 33.7% from 2016 to 2021.The growth in this market can be mainly attributed to the growing clinical applications of holography in the healthcare sector, rising adoption of holography products in biomedical research and medical education, and emergence of holography as a promising technology in representing complex 3D structures.In this report, the global Medical Holography Market is segmented on the basis of product type, application, end user, and region.Based on product type, the market is segmented into holographic displays, holography microscopes, holographic prints, holography software and holoscopes.On the basis of application, the Medical Holography Market is segmented into three segments namely medical imaging, medical education, and biomedical research.While on the basis of end user, the Medical Holography Market is segmented into research laboratories, academic medical centers, pharmaceutical and biotechnology companies, and hospitals and clinics.In 2015, the holographic displays product segment accounted for the largest share of the Medical Holography Market.This market is primarily driven by the increasing adoption of holographic displays in diagnostic imaging and for medical teaching and training as these displays provide high-quality real-time 3D images which attracts the user effectively.Download PDF Brochures – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183930222In 2015, North America represented the largest regional market, followed by Europe, Asia-Pacific, and the RoW.North America represents the fastest-growing region for the Medical Holography Market, primarily due to increasing research initiatives in holography technology, adoption of holographic products by research laboratories and academic centers, and increasing healthcare expenditure in the U.S.The medical holography market in North America is expected to grow at the highest CAGR during the forecast period.Factors such as increasing demand for noninvasive and radiation-free imaging techniques coupled with the growing geriatric population and increasing number of imaging procedures across the region are driving the growth of regional market.Know more about Medical Holography Market – https://www.marketsandmarkets.com/PressReleases/medical-holography.asp
2
IN
The computer-assisted coding market is expanding with the emergence of new products and applications.These computer assisted coding solutions being used in many applications such as automated computer-assisted encoding, management reporting & analytics, and clinical coding auditing.What the Computer Assisted Coding Market Looks Like?Predicted to grow at a CAGR of 11.5% during the forecast period, the global Computer Assisted Coding Market is estimated to reach USD 4.75 Billion by the end of 2022.The growth of the market can be attributed to the transition to ICD-10 coding standards from ICD-9 in North America, the growing demand for CAC solutions, the growing need within the global healthcare system to curtail increasing healthcare costs, improve coding accuracy, and streamline the revenue cycle management procedures.Implementation of ICD-10 Drive the Global Computer Assisted Coding MarketMany hospitals, especially in North America, are adopting CAC systems to manage the increasing load of coding resulting from the adoption of ICD-10 standards.Major health plans like Medicare have reported a smooth transition to ICD-10 due to rigorous testing for over six years.The ICD-10 coding system requires the use of 72,000 procedure codes and 68,000 CM codes, as opposed to the 4,000 and 14,000 codes, respectively, in the ICD-9 system.The implementation of CAC systems can resolve this issue as they enable healthcare organizations to work more efficiently while complying with procedural coding standards as per ICD-10 guidelines.
2
IN
Surgical Drapes and Gowns Market is expected to reach USD 3.14 Billion by 2023 from USD 2.47 Billion in 2018, at a CAGR of 4.9%.Factors such as the increasing number of surgeries and the growing incidence of hospital-acquired infections is driving the growth of this market.Covid Impact on Surgical Drapes and Gowns Market, growth/decline in product type/use cases of Surgical Drapes and Gowns Market due to cascaded impact of Covid on Extended Ecosystem.How top 50 companies in Surgical Drapes and Gowns Market are making rapid shifts in their strategies as we speak here.Outside-in view of top 50 companies client and client’s clients shifting short-term priorities.We salute industry experts helping companies survive and sustain in this economic pandemic; they are working day and night to help companies take rapid-decisions by finding.Let’s fight this crisis together.https://www.marketsandmarkets.com/RequestCOVID19.asp?id=210282118According to the new market research “Surgical Drapes and Gowns Market by Type (Drapes (Cardiovascular, General Surgery, C- Section, Lithotomy, Laparoscopy, Ophthalmic), Gown (Standard, Reinforced, High-Performance)), Utility (Reusable, Disposable), End User (Hospital) — Global Forecast to 2023” published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.By type, the surgical drapes and gowns market is classified into surgical drapes and surgical gowns.The surgical drapes segment is expected to lead the global market in 2017.Factors driving the growth of this segment include increasing adoption of surgical drapes in hospitals and ambulatory surgical centers, rising number of surgeries owing to the increasing incidences of chronic diseases and increasing demand for prevention from surgical site infection.Based on usage pattern, the surgical drapes and gowns market is categorized into disposable surgical drapes & gowns and reusable surgical drapes & gowns.The disposable surgical drapes and gowns segment is estimated to grow at the highest rate during the forecast period.
1
IN
In the current regulatory climate-where the focus on sustainable techniques has risen-it is expected that the benefits of cold plasma will ensure its greater adoption in the years to come.Innovations in textile production and growing food safety concerns are the major factors driving the growth of this market.What the Cold Plasma Market Looks Like?Predicted to grow at a CAGR of 15.6% during the forecast period, the global Cold Plasma Market is estimated to reach USD 3.1 Billion by the end of 2024.Europe is expected to account for the largest share of the cold plasma market in 2019, followed by North America.The large share of Europe in the global market can be attributed to the presence of a large number of cold plasma companies and growing R work in Germany.By Textile Industry, the finishing segment is to dominate the cold plasma industry share in 2019Based on industry, the cold plasma industry has been segmented into the textile industry, polymer & plastic industry, electronics & semiconductors industry, food & agriculture, and medical industry.Within the textile industry, the finishing segment accounted for the largest share in 2018.The large share of this segment can be attributed to the cost-effective and environmental-friendly cold plasma as compared to conventional treatments for textile finishing.By Regime, the atmospheric cold plasma segment is expected to grow at the highest CAGR during the forecast period (2019-2024)Based on the regime, the cold plasma market has been segmented into atmospheric cold plasma and low-pressure cold plasma.
3
IN
The emerging markets, growing government and private investments to meet the increasing demand for breast cancer screening, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players.The breast imaging market is projected to grow from an estimated USD 3.1 billion in 2018 to USD 4.6 billion by 2023, at a CAGR of 8.0% during the forecast period.The breast imaging market is primarily driven by the rising prevalence of breast cancer.In addition, technological advancements in breast imaging modalities have allowed for quicker, more accurate, and convenient functionalities, while favorable government investments and the availability of funding have increased access to breast imaging modalities.However, factors such as errors in screening and misdiagnosis, the side-effects of radiation exposure, and the growing adoption of refurbished imaging systems—mainly due to the high costs of new products—are expected to hinder the growth of the breast imaging market during the forecast period.Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897Growing incidence of breast cancerBreast cancer is among the most common cancers affecting women in developed as well as developing countries.The growing incidence of breast cancer cases leads to an increased burden on governments to raise awareness about the importance of early detection of breast cancer.Thus, with the sharp rise in breast cancer cases, the demand for breast imaging solutions is expected to grow considerably in the coming years.High Cost of Breast Imaging SystemsBreast imaging systems are priced at a premium and require high investments for installations, which increases the procedural cost for patients as well.Healthcare facilities that purchase such costly systems often depend on third-party payers for reimbursements for costs incurred in screening and diagnostic procedures performed with these systems.
IN
The report “Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) – Global Forecast to 2024″, is projected to grow at a CAGR of 14.5% during the forecast period, to reach USD 207 billion by 2024 from USD 105 billion in 2019.Factors such as the increasing funds and grants by government bodies and universities for the development of novel biomaterials, increasing demand for implantable devices, growing demand for biomaterials in plastic surgery and wound healing applications, rising incidence of cardiovascular diseases, and rising awareness and research on regenerative medicine are driving the growth of the biomaterials market during the forecast period.Metallic biomaterials accounted for the largest share of the biomaterials market in 2018The metallic biomaterials segment accounted for the largest share of the biomaterials market, by type, in 2018.This is primarily attributed to the wide use of metals in the manufacturing of medical devices used in cardiovascular, dental, and orthopedic applications.It is expected that the rise in geriatric population globally will increase the demand for these devices, as age increases susceptibility to orthopedic, dental, ophthalmological, neurological, and cardiovascular disorders.This number is expected to reach 3.48 million procedures per year by 2030.Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=393Cardiovascular applications segment accounted for the largest share of the biomaterials market in 2018The cardiovascular applications segment accounted for the largest share of the biomaterials market, by application, in 2018.For instance, according to the World Health Organization (WHO), 17.9 million people die each year from CVDs, which is an estimated 31% of all deaths worldwide.
More

Top